Skip to main content

Table 1 Response according to HDFN risk, as established upon first trimester RBC antibody screening

From: Women's attitude towards prenatal screening for red blood cell antibodies, other than RhD

Groups according to risk for HDFN

Questionnaire 1 completed

no

Questionnaire 1 + 2 completed

no (%)

A1. controls midwifery practice, screening negative

61

58 (95)

A2. controls hospital practice, screening negative

41

35 (85)

B. positive screening result, not confirmed

24

21 (88)

C. clinically non-relevant antibodies

48

44 (92)

D. clinically relevant non-RhD antibodies, not at risk HDFN (father antigen-negative)

37

30 (81)

E. clinically relevant non-RhD antibodies, at risk HDFN (father antigen-positive)

52

45 (87)

Total

263

233 (89)

  1. No significant differences in response between the groups